This is a proposal to renew a T32 grant to support training for nine physicians committed to a career in cancer research. The goal of this program is to train the next generation of medical, pediatric, surgical, and radiation oncologists in the basic methods and concepts of cancer research, strengthening the ties between the laboratory and clinic. The program is multispecialty and multidisciplinary in its orientation and governance, and includes laboratories and mentors that represent all of the clinical subspecialties of cancer and a broad array of research interests. The program emphasizes the importance of translating new findings in the fields of cancer biology, genetics, experimental therapeutics, immunology, molecular imaging, and epidemiology into useful clinical """"""""application. The pool of candidates is derived primarily from the Massachusetts General Hospital (MGH) clinical residency and fellowship programs in medical oncology, radiation oncology, surgery, and orthopedic oncology. The quality of these candidates is outstanding. The mentors are similarly outstanding, contributing the highest quality research and teaching. The mentors are based mainly at the MGH Cancer Center, but are also from). Mentors interact extensively through their research collaborations and participation in the cancer center. This training program and the cancer center are built on the cornerstone of integrating laboratory, clinical, and population science research through disease-based programs which have been established for each type of cancer. The program provides both project-oriented research experience and complementary didactic education for trainees. A high priority is placed on careful monitoring of trainees'progress by the program Director and Co-director, the Executive Committee, and individual mentors, including regular written reports from the trainees and mentors. The track record of former program trainees serves as a strong endorsement of the quality of this program. The program actively recruits women and minority candidates, and new mechanisms have been implemented to enhance these efforts. Relevance to Public Health: This project helps to train young physicians for a future career in clinical research and to enhance their knowledge and expertise in the treatment of cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA071345-14
Application #
7918928
Study Section
Special Emphasis Panel (ZCA1-RTRB-A (M1))
Program Officer
Damico, Mark W
Project Start
1997-08-01
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
14
Fiscal Year
2010
Total Cost
$265,736
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Jalbut, Marla M; Brunner, Andrew M; Amrein, Philip C et al. (2018) Early infectious complications among patients treated with induction compared to hypomethylating therapy for acute myeloid leukemia. Leuk Lymphoma 59:988-991
Sahin, Ayguen; Sanchez, Carlos; Bullain, Szofia et al. (2018) Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-expressing artificial antigen presenting cells for adoptive cell therapy for glioma. PLoS One 13:e0199414
Spring, Laura M; Marshall, Megan R; Warner, Erica T (2017) Mammography decision making: Trends and predictors of provider communication in the Health Information National Trends Survey, 2011 to 2014. Cancer 123:401-409
Micalizzi, Douglas S; Haber, Daniel A; Maheswaran, Shyamala (2017) Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells. Mol Oncol 11:770-780
Spring, Laura; Greenup, Rachel; Niemierko, Andrzej et al. (2017) Pathologic Complete Response After Neoadjuvant Chemotherapy and Long-Term Outcomes Among Young Women With Breast Cancer. J Natl Compr Canc Netw 15:1216-1223
Spring, Laura M; Zangardi, Mark L; Moy, Beverly et al. (2017) Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations. Oncologist 22:1039-1048
Perry, Ashley M; Brunner, Andrew M; Zou, Tao et al. (2017) Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: A population-based study. Cancer 123:2561-2569
Brunner, Andrew M; Hobbs, Gabriela; Jalbut, Marla M et al. (2016) A population-based analysis of second malignancies among patients with myeloproliferative neoplasms in the SEER database. Leuk Lymphoma 57:1197-200
Brunner, Andrew M; Steensma, David P (2016) Myelodysplastic syndrome associated with acquired beta thalassemia: ""BTMDS"". Am J Hematol 91:E325-7
Nipp, Ryan D; Greer, Joseph A; El-Jawahri, Areej et al. (2016) Age and Gender Moderate the Impact of Early Palliative Care in Metastatic Non-Small Cell Lung Cancer. Oncologist 21:119-26

Showing the most recent 10 out of 66 publications